Prospects of Molecular Biotechnology in Diagnostics: Step Towards Precision Medicine.
作者信息
Sharma Praveen, Dwivedi Shailendra
机构信息
Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, 342005 India.
出版信息
Indian J Clin Biochem. 2017 Jun;32(2):121-123. doi: 10.1007/s12291-017-0650-9. Epub 2017 Apr 3.
Abstract
摘要
相似文献
1
Prospects of Molecular Biotechnology in Diagnostics: Step Towards Precision Medicine.
Indian J Clin Biochem. 2017 Jun;32(2):121-123. doi: 10.1007/s12291-017-0650-9. Epub 2017 Apr 3.
2
David Bowie and the Art of Slow Innovation: A Fast-Second Winner Strategy for Biotechnology and Precision Medicine Global Development.
OMICS. 2017 Nov;21(11):633-637. doi: 10.1089/omi.2017.0148. Epub 2017 Oct 24.
3
Mayo's impact on patent applications related to biotechnology, diagnostics and personalized medicine.
Nat Biotechnol. 2019 May;37(5):513-518. doi: 10.1038/s41587-019-0111-5.
4
Companion diagnostics: the next step in personalized clinical care.
Genet Test Mol Biomarkers. 2012 Oct;16(10):1155-6. doi: 10.1089/gtmb.2012.1539.
5
Personalised medicine in 2012: editorial to the special issue of New Biotechnology on "molecular diagnostics & personalised medicine".
N Biotechnol. 2012 Sep 15;29(6):611-2. doi: 10.1016/j.nbt.2012.03.010. Epub 2012 Apr 5.
6
Precision Medicine in Pediatric Cancer: Current Applications and Future Prospects.
High Throughput. 2018 Dec 13;7(4):39. doi: 10.3390/ht7040039.
7
Diseases and Molecular Diagnostics: A Step Closer to Precision Medicine.
Indian J Clin Biochem. 2017 Oct;32(4):374-398. doi: 10.1007/s12291-017-0688-8. Epub 2017 Aug 22.
8
Application of biotechnology methods to the study of cestodes.
Southeast Asian J Trop Med Public Health. 1988 Mar;19(1):35-40.
9
National seminar on biotechnology--challenges and prospects.
Indian J Exp Biol. 2002 Jun;40(6):745-6.
10
[Nanobiotechnology and nanomedicine].
Biomed Khim. 2006 Nov-Dec;52(6):529-46.
引用本文的文献
1
Unveiling the Zinc Paradox: Balancing Act in Reproductive Health and Prostate Pathology.
Indian J Clin Biochem. 2025 Apr;40(2):316-317. doi: 10.1007/s12291-024-01183-2. Epub 2024 Feb 5.
2
MicroRNA Significance in Cancer: An Updated Review on Diagnostic, Prognostic, and Therapeutic Perspectives.
EJIFCC. 2024 Dec 30;35(4):265-284. eCollection 2024 Dec.
3
Occupational and Environmental Exposure Influences the Inflammatory (Pro-and Anti-) Status in Benign Prostate Hyperplasia and Prostate Carcinoma Patients: A Retrospective Analysis.
Indian J Clin Biochem. 2024 Apr;39(2):241-247. doi: 10.1007/s12291-023-01112-9. Epub 2023 Jan 13.
4
Novel Stem Cells and Nucleic Acid-Based Vaccine Trials Against Viral Outbreak: A Systematic Evaluation During COVID-2019 Pandemic.
Indian J Clin Biochem. 2020 Oct;35(4):397-409. doi: 10.1007/s12291-020-00907-4. Epub 2020 Jul 10.
5
MicroRNAs and Diseases: Promising Biomarkers for Diagnosis and Therapeutics.
Indian J Clin Biochem. 2019 Jul;34(3):243-245. doi: 10.1007/s12291-019-00844-x. Epub 2019 Jul 19.
6
Methods for Isolation of High Quality and Quantity of miRNA and Single Cell Suspension for Flow-Cytometry from Breast Cancer Tissue: A Comparative Analysis.
Indian J Clin Biochem. 2019 Jan;34(1):39-44. doi: 10.1007/s12291-017-0719-5. Epub 2017 Nov 29.
7
Single Cell Omics of Breast Cancer: An Update on Characterization and Diagnosis.
Indian J Clin Biochem. 2019 Jan;34(1):3-18. doi: 10.1007/s12291-019-0811-0. Epub 2019 Jan 8.
8
Tissue-Resident Memory Cells: New Marked Shield to Fight Cancers.
Indian J Clin Biochem. 2018 Apr;33(2):119-120. doi: 10.1007/s12291-018-0745-y. Epub 2018 Mar 7.
9
Diseases and Molecular Diagnostics: A Step Closer to Precision Medicine.
Indian J Clin Biochem. 2017 Oct;32(4):374-398. doi: 10.1007/s12291-017-0688-8. Epub 2017 Aug 22.
10
Nutrigenomics and Nutrigenetics: New Insight in Disease Prevention and Cure.
Indian J Clin Biochem. 2017 Oct;32(4):371-373. doi: 10.1007/s12291-017-0699-5. Epub 2017 Sep 22.
本文引用的文献
1
Integration of molecular pathology, epidemiology and social science for global precision medicine.
Expert Rev Mol Diagn. 2016;16(1):11-23. doi: 10.1586/14737159.2016.1115346. Epub 2015 Dec 4.
2
Functional genetic variability at promoters of pro-(IL-18) and anti-(IL-10) inflammatory affects their mRNA expression and survival in prostate carcinoma patients: Five year follow-up study.
Prostate. 2015 Nov;75(15):1737-46. doi: 10.1002/pros.23055. Epub 2015 Aug 17.
3
Genetic variability at promoters of IL-18 (pro-) and IL-10 (anti-) inflammatory gene affects susceptibility and their circulating serum levels: An explorative study of prostate cancer patients in North Indian populations.
Cytokine. 2015 Jul;74(1):117-22. doi: 10.1016/j.cyto.2015.04.001. Epub 2015 Apr 16.
4
Tobacco exposure by various modes may alter proinflammatory (IL-12) and anti-inflammatory (IL-10) levels and affects the survival of prostate carcinoma patients: an explorative study in North Indian population.
Biomed Res Int. 2014;2014:158530. doi: 10.1155/2014/158530. Epub 2014 Aug 7.
5
Advancing the education in molecular diagnostics: the IFCC-Initiative "Clinical Molecular Biology Curriculum" (C-CMBC); a ten-year experience.
Clin Chim Acta. 2014 Sep 25;436:5-8. doi: 10.1016/j.cca.2014.04.031. Epub 2014 May 9.
6
Non-invasive biomarker in prostate carcinoma: a novel approach.
Indian J Clin Biochem. 2013 Apr;28(2):107-9. doi: 10.1007/s12291-013-0312-5.
Zotero 插件